GGrantIndex
← Search

OPTIMIZING ACTIVE IMMUNOTHERAPY OF MELANOMA THROUGH METABOLIC REPROGRAMMING OF MELANOMA ANTIGEN-SPECIFIC CD8+ T CELLS COMBINED WITH CHECKPOINT BLOCKADE

$1,746,270FY2019Department of the ArmyDOD

The Wistar Institute Of Anatomy And Biology

Investigators

View source on USAspending →
OPTIMIZING ACTIVE IMMUNOTHERAPY OF MELANOMA THROUGH METABOLIC REPROGRAMMING OF MELANOMA ANTIGEN-SPECIFIC CD8+ T CELLS COMBINED WITH CHECKPOINT BLOCKADE · GrantIndex